Masimo Corporation $MASI Shares Sold by Citigroup Inc.

Key Points

• Citigroup Inc. reduced its stake in Masimo Corporation by 43.1% in the first quarter, owning approximately 0.10% of the company valued at $8.69 million after selling 39,533 shares.
• Masimo reported earnings of $1.33 per share for the last quarter, surpassing analyst expectations of $1.22, alongside a revenue increase of 7.7% year-over-year.
• In recent stock movement, Masimo's shares opened at $153.87 and it has a market capitalization of $8.36 billion, with institutional investors owning 85.96% of the company’s stock.

Citigroup Inc. reduced its position in Masimo Corporation (NASDAQ:MASI - Free Report) by 43.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 52,158 shares of the medical equipment provider's stock after selling 39,533 shares during the period. Citigroup Inc. owned 0.10% of Masimo worth $8,690,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Farther Finance Advisors LLC boosted its holdings in shares of Masimo by 128.9% in the 1st quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 116 shares in the last quarter. NBC Securities Inc. purchased a new position in shares of Masimo in the 1st quarter valued at approximately $61,000. UMB Bank n.a. raised its position in shares of Masimo by 134.0% in the 1st quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock valued at $74,000 after purchasing an additional 256 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Masimo by 58.4% in the 1st quarter. GAMMA Investing LLC now owns 738 shares of the medical equipment provider's stock valued at $123,000 after purchasing an additional 272 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Masimo in the 4th quarter valued at approximately $163,000. 85.96% of the stock is currently owned by institutional investors.

Insider Transactions at Masimo

In related news, Director William R. Jellison purchased 3,000 shares of the company's stock in a transaction that occurred on Monday, August 11th. The shares were purchased at an average price of $145.98 per share, with a total value of $437,940.00. Following the purchase, the director owned 4,790 shares of the company's stock, valued at $699,244.20. The trade was a 167.60% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 16.90% of the company's stock.

Wall Street Analyst Weigh In

MASI has been the subject of several research analyst reports. Raymond James Financial decreased their price objective on shares of Masimo from $204.00 to $185.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. Piper Sandler increased their price objective on shares of Masimo from $200.00 to $210.00 and gave the company an "overweight" rating in a research report on Wednesday, August 6th. BTIG Research reaffirmed a "buy" rating on shares of Masimo in a research report on Thursday, August 14th. Wells Fargo & Company decreased their price objective on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a research report on Wednesday, May 7th. Finally, Wall Street Zen lowered shares of Masimo from a "buy" rating to a "hold" rating in a research report on Friday, May 30th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $193.60.

Masimo Price Performance

Masimo stock traded down $0.2110 during trading on Wednesday, reaching $146.5490. The company had a trading volume of 251,459 shares, compared to its average volume of 633,002. The firm's 50-day simple moving average is $160.29 and its 200 day simple moving average is $163.48. Masimo Corporation has a 1-year low of $107.98 and a 1-year high of $194.88. The firm has a market capitalization of $7.96 billion, a PE ratio of -17.22 and a beta of 1.21. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.11. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The firm had revenue of $370.90 million for the quarter, compared to analysts' expectations of $368.65 million. During the same quarter last year, the company earned $0.86 EPS. The firm's revenue for the quarter was up 7.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Masimo Corporation will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.